ID   VP1_SV40                Reviewed;         362 AA.
AC   P03087;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   03-AUG-2022, entry version 156.
DE   RecName: Full=Major capsid protein VP1;
DE   AltName: Full=Major structural protein VP1;
OS   Simian virus 40 (SV40).
OC   Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Papovaviricetes;
OC   Sepolyvirales; Polyomaviridae; Betapolyomavirus.
OX   NCBI_TaxID=1891767;
OH   NCBI_TaxID=9539; Macaca (macaques).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=205947; DOI=10.1126/science.205947;
RA   Reddy V.B., Thimmappaya B., Dhar R., Subramanian K.N., Zain B.S., Pan J.,
RA   Ghosh P.K., Celma M.L., Weissman S.M.;
RT   "The genome of simian virus 40.";
RL   Science 200:494-502(1978).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=776;
RX   PubMed=205802; DOI=10.1038/273113a0;
RA   Fiers W., Contreras R., Haegeman G., Rogiers R., van de Voorde A.,
RA   van Heuverswyn H., van Herreweghe J., Volckaert G., Ysebaert M.;
RT   "Complete nucleotide sequence of SV40 DNA.";
RL   Nature 273:113-120(1978).
RN   [3]
RP   PROTEIN SEQUENCE.
RX   PubMed=224033; DOI=10.1016/s0021-9258(18)35981-7;
RA   Kempe T.D., Beattie W.G., Weissman S., Konigsberg W.;
RT   "Correlation of the protein and nucleic acid sequences for the major
RT   structural protein of simian virus 40.";
RL   J. Biol. Chem. 254:7561-7569(1979).
RN   [4]
RP   VIRION ASSEMBLY.
RX   PubMed=13963379; DOI=10.1083/jcb.17.2.423;
RA   Granboulan N., Tournier P., Wicker R., Bernhard W.;
RT   "An electron microscope study of the development of SV40 virus.";
RL   J. Cell Biol. 17:423-441(1963).
RN   [5]
RP   PHOSPHORYLATION AT THR-338.
RX   PubMed=2464591; DOI=10.1016/s0021-9258(19)81665-4;
RA   Babe L.M., Brew K., Matsuura S.E., Scott W.A.;
RT   "Epitopes on the major capsid protein of simian virus 40.";
RL   J. Biol. Chem. 264:2665-2671(1989).
RN   [6]
RP   NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=8551602; DOI=10.1128/jvi.70.2.1317-1322.1996;
RA   Ishii N., Minami N., Chen E.Y., Medina A.L., Chico M.M., Kasamatsu H.;
RT   "Analysis of a nuclear localization signal of simian virus 40 major capsid
RT   protein Vp1.";
RL   J. Virol. 70:1317-1322(1996).
RN   [7]
RP   DISULFIDE BONDS IN INTER-PENTAMER.
RX   PubMed=10501505; DOI=10.1099/0022-1317-80-9-2481;
RA   Jao C.C., Weidman M.K., Perez A.R., Gharakhanian E.;
RT   "Cys9, Cys104 and Cys207 of simian virus 40 Vp1 are essential for inter-
RT   pentamer disulfide-linkage and stabilization in cell-free lysates.";
RL   J. Gen. Virol. 80:2481-2489(1999).
RN   [8]
RP   INTERACTION WITH HOST HSPA8.
RX   PubMed=11147964; DOI=10.1379/1466-1268(2000)005<0132:hiwsvp>2.0.co;2;
RA   Sainis L., Angelidis C., Pagoulatos G.N., Lazaridis L.;
RT   "HSC70 interactions with SV40 viral proteins differ between permissive and
RT   nonpermissive mammalian cells.";
RL   Cell Stress Chaperones 5:132-138(2000).
RN   [9]
RP   DNA-BINDING, NUCLEAR LOCALIZATION SIGNAL, AND SUBCELLULAR LOCATION.
RX   PubMed=11462004; DOI=10.1128/jvi.75.16.7321-7329.2001;
RA   Li P.P., Nakanishi A., Shum D., Sun P.C., Salazar A.M., Fernandez C.F.,
RA   Chan S.W., Kasamatsu H.;
RT   "Simian virus 40 Vp1 DNA-binding domain is functionally separable from the
RT   overlapping nuclear localization signal and is required for effective
RT   virion formation and full viability.";
RL   J. Virol. 75:7321-7329(2001).
RN   [10]
RP   INTERACTION WITH HOST SP1.
RX   PubMed=12021324; DOI=10.1128/jvi.76.12.5915-5924.2002;
RA   Gordon-Shaag A., Ben-Nun-Shaul O., Roitman V., Yosef Y., Oppenheim A.;
RT   "Cellular transcription factor Sp1 recruits simian virus 40 capsid proteins
RT   to the viral packaging signal, ses.";
RL   J. Virol. 76:5915-5924(2002).
RN   [11]
RP   MUTAGENESIS OF GLU-49; GLU-217 AND GLU-331.
RX   PubMed=12805453; DOI=10.1128/jvi.77.13.7527-7538.2003;
RA   Li P.P., Naknanishi A., Tran M.A., Ishizu K., Kawano M., Phillips M.,
RA   Handa H., Liddington R.C., Kasamatsu H.;
RT   "Importance of Vp1 calcium-binding residues in assembly, cell entry, and
RT   nuclear entry of simian virus 40.";
RL   J. Virol. 77:7527-7538(2003).
RN   [12]
RP   MUTAGENESIS OF CYS-50; CYS-88; CYS-255 AND CYS-268.
RX   PubMed=15567029; DOI=10.1016/j.virusres.2004.06.006;
RA   Gharakhanian E., Mana W., Norng M.;
RT   "Cys254 and Cys49/Cys87of simian virus 40 Vp1 are essential in formation of
RT   infectious virions.";
RL   Virus Res. 107:21-25(2005).
RN   [13]
RP   INTERACTION WITH VP2 AND VP3, AND MUTAGENESIS OF VAL-244 AND LEU-246.
RX   PubMed=16940501; DOI=10.1128/jvi.00781-06;
RA   Nakanishi A., Nakamura A., Liddington R., Kasamatsu H.;
RT   "Identification of amino acid residues within simian virus 40 capsid
RT   proteins Vp1, Vp2, and Vp3 that are required for their interaction and for
RT   viral infection.";
RL   J. Virol. 80:8891-8898(2006).
RN   [14]
RP   MUTAGENESIS OF GLU-158 AND GLU-161.
RX   PubMed=17360742; DOI=10.1128/jvi.02195-06;
RA   Li P.P., Nguyen A.P., Qu Q., Jafri Q.H., Aungsumart S., Cheng R.H.,
RA   Kasamatsu H.;
RT   "Importance of calcium-binding site 2 in simian virus 40 infection.";
RL   J. Virol. 81:6099-6105(2007).
RN   [15]
RP   ISOMERIZATION OF DISULFIDE BONDS, AND FUNCTION.
RX   PubMed=17981119; DOI=10.1016/j.cell.2007.09.038;
RA   Schelhaas M., Malmstroem J., Pelkmans L., Haugstetter J., Ellgaard L.,
RA   Gruenewald K., Helenius A.;
RT   "Simian Virus 40 depends on ER protein folding and quality control factors
RT   for entry into host cells.";
RL   Cell 131:516-529(2007).
RN   [16]
RP   REVIEW.
RX   PubMed=19157478; DOI=10.1016/j.virol.2008.12.021;
RA   Neu U., Stehle T., Atwood W.J.;
RT   "The Polyomaviridae: Contributions of virus structure to our understanding
RT   of virus receptors and infectious entry.";
RL   Virology 384:389-399(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (3.8 ANGSTROMS).
RX   PubMed=1659663; DOI=10.1038/354278a0;
RA   Liddinngton R.C., Yan Y., Moulai J., Sahli R., Benjamin T.L.,
RA   Harrison S.C.;
RT   "Structure of simian virus 40 at 3.8-A resolution.";
RL   Nature 354:278-284(1991).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 2-362, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=8805523; DOI=10.1016/s0969-2126(96)00020-2;
RA   Stehle T., Gamblin S.J., Yan Y., Harrison S.C.;
RT   "The structure of simian virus 40 refined at 3.1-A resolution.";
RL   Structure 4:165-182(1996).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 31-298, AND FUNCTION.
RX   PubMed=18353982; DOI=10.1073/pnas.0710301105;
RA   Neu U., Woellner K., Gauglitz G., Stehle T.;
RT   "Structural basis of GM1 ganglioside recognition by simian virus 40.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:5219-5224(2008).
CC   -!- FUNCTION: Forms an icosahedral capsid with a T=7 symmetry and a 40 nm
CC       diameter. The capsid is composed of 72 pentamers linked to each other
CC       by disulfide bonds and associated with VP2 or VP3 proteins. Binds to N-
CC       glycolylneuraminic analog of the ganglioside GM1 on the cell surface to
CC       provide virion attachment to target cell (PubMed:18353982). Once
CC       attached, the virion is internalized by caveolin-mediated endocytosis
CC       and traffics to the endoplasmic reticulum. Inside the endoplasmic
CC       reticulum, the protein folding machinery isomerizes VP1 interpentamer
CC       disulfide bonds, thereby triggering initial uncoating
CC       (PubMed:17981119). Next, the virion uses the endoplasmic reticulum-
CC       associated degradation machinery to probably translocate in the cytosol
CC       before reaching the nucleus (PubMed:17981119). Nuclear entry of the
CC       viral DNA involves the selective exposure and importin recognition of
CC       VP2/Vp3 nuclear localization signal. The assembly takes place in the
CC       cell nucleus. Encapsulates the genomic DNA and participates in
CC       rearranging nucleosomes around the viral DNA. The viral progenies exit
CC       the cells by lytic release. {ECO:0000269|PubMed:17981119,
CC       ECO:0000269|PubMed:18353982, ECO:0000305|PubMed:19157478}.
CC   -!- SUBUNIT: Homomultimer; disulfide-linked. The virus capsid is composed
CC       of 72 icosahedral units, each one composed of five disulfide-linked
CC       copies of VP1. Interacts with agnoprotein (By similarity). Interacts
CC       with minor capsid proteins VP2 and VP3. Interacts with host HSPA8; this
CC       interaction probably participates in virus assembly. Interacts with
CC       host SP1; this interaction enhances the efficiency of viral packaging.
CC       {ECO:0000250, ECO:0000269|PubMed:10501505, ECO:0000269|PubMed:11147964,
CC       ECO:0000269|PubMed:12021324, ECO:0000269|PubMed:16940501,
CC       ECO:0000269|PubMed:8805523}.
CC   -!- INTERACTION:
CC       P03087; P03087: -; NbExp=3; IntAct=EBI-1555770, EBI-1555770;
CC       P03087; O92837: VP3; NbExp=3; IntAct=EBI-1555770, EBI-7196689;
CC       P03087; P03093; NbExp=3; IntAct=EBI-1555770, EBI-1555798;
CC       P03087; P11103: Parp1; Xeno; NbExp=2; IntAct=EBI-1555770, EBI-642213;
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000269|PubMed:8805523}. Host nucleus
CC       {ECO:0000269|PubMed:11462004}. Host endoplasmic reticulum
CC       {ECO:0000305|PubMed:19157478}. Note=Following host cell entry, the
CC       virion enters into the endoplasmic reticulum through a calveolar-
CC       dependent pathway. Then, viral DNA is translocated to the nucleus.
CC       Shortly after synthesis, a nuclear localization signal directs VP1 to
CC       the cell nucleus where virion assembly occurs.
CC       {ECO:0000305|PubMed:19157478}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=5;
CC       Name=VP1; Synonyms=Major capsid protein VP1;
CC         IsoId=P03087-1; Sequence=Displayed;
CC       Name=VP2; Synonyms=Minor capsid protein VP2;
CC         IsoId=P03093-1; Sequence=External;
CC       Name=VP3; Synonyms=Minor capsid protein VP3;
CC         IsoId=P03093-2; Sequence=External;
CC       Name=VP4; Synonyms=Viroporin VP4;
CC         IsoId=P03093-3; Sequence=External;
CC       Name=Agno;
CC         IsoId=P03084-1; Sequence=External;
CC   -!- DOMAIN: The intrinsically disordered C-terminal arm interacts with
CC       neighboring pentamers. The unstructured nature of this region allows to
CC       make different interactions depending on the structural context:
CC       pentamers present at the 12 icosahedral fivefold axes bind five
CC       pentamers, whereas pentamers present at the 60 icosahedral six-fold
CC       axes interact with six pentamers. {ECO:0000269|PubMed:1659663,
CC       ECO:0000269|PubMed:8805523}.
CC   -!- DOMAIN: A DNA-binding domain overlapping a bipartite nuclear
CC       localization signal is present in the N-terminal region of the protein
CC       and is required for efficient virus formation.
CC       {ECO:0000269|PubMed:11462004}.
CC   -!- MISCELLANEOUS: [Isoform VP1]: Produced by alternative splicing of the
CC       late mRNA (16s mRNA).
CC   -!- SIMILARITY: Belongs to the polyomaviruses coat protein VP1 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral capsid
CC       structure;
CC       URL="https://viperdb.scripps.edu/Info_Page.php?VDB=1sva";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02400; AAB59923.1; -; Genomic_DNA.
DR   PIR; A31426; A31426.
DR   PIR; E03631; VVVP14.
DR   RefSeq; YP_003708381.1; NC_001669.1.
DR   PDB; 1SVA; X-ray; 3.10 A; 1/2/3/4/5/6=2-362.
DR   PDB; 3BWQ; X-ray; 2.30 A; A/B/C/D/E=31-298.
DR   PDB; 3BWR; X-ray; 2.25 A; A/B/C/D/E=31-298.
DR   PDBsum; 1SVA; -.
DR   PDBsum; 3BWQ; -.
DR   PDBsum; 3BWR; -.
DR   SMR; P03087; -.
DR   DIP; DIP-29870N; -.
DR   IntAct; P03087; 3.
DR   MINT; P03087; -.
DR   UniLectin; P03087; -.
DR   iPTMnet; P03087; -.
DR   EvolutionaryTrace; P03087; -.
DR   Proteomes; UP000007705; Genome.
DR   GO; GO:0046727; C:capsomere; IDA:CAFA.
DR   GO; GO:0044165; C:host cell endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0042025; C:host cell nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0039620; C:T=7 icosahedral viral capsid; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IDA:CAFA.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0075513; P:caveolin-mediated endocytosis of virus by host cell; IEA:UniProtKB-KW.
DR   GO; GO:0019069; P:viral capsid assembly; IDA:CAFA.
DR   GO; GO:0019062; P:virion attachment to host cell; IEA:UniProtKB-KW.
DR   DisProt; DP00182; -.
DR   Gene3D; 2.60.175.10; -; 1.
DR   InterPro; IPR000662; Capsid_VP1_Polyomavir.
DR   InterPro; IPR011222; dsDNA_vir_gr_I_capsid.
DR   InterPro; IPR036931; Polyomavir_VP1_sf.
DR   Pfam; PF00718; Polyoma_coat; 1.
DR   PIRSF; PIRSF003376; Capsid_VP1_Polyomavir; 1.
DR   SUPFAM; SSF88648; SSF88648; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing; Capsid protein;
KW   Caveolin-mediated endocytosis of virus by host; Direct protein sequencing;
KW   Disulfide bond; Host endoplasmic reticulum; Host nucleus;
KW   Host-virus interaction; Late protein; Phosphoprotein; Reference proteome;
KW   T=7 icosahedral capsid protein; Viral attachment to host cell;
KW   Viral penetration into host cytoplasm; Virion; Virus endocytosis by host;
KW   Virus entry into host cell.
FT   INIT_MET        1
FT                   /note="Removed; by host"
FT   CHAIN           2..362
FT                   /note="Major capsid protein VP1"
FT                   /id="PRO_0000115028"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          302..362
FT                   /note="C-terminal arm"
FT                   /evidence="ECO:0000269|PubMed:1659663,
FT                   ECO:0000269|PubMed:8805523"
FT   MOTIF           5..19
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:11462004,
FT                   ECO:0000269|PubMed:8551602"
FT   MOD_RES         338
FT                   /note="Phosphothreonine; by host"
FT                   /evidence="ECO:0000269|PubMed:2464591"
FT   DISULFID        10
FT                   /note="Interchain"
FT                   /evidence="ECO:0000269|PubMed:10501505"
FT   DISULFID        105
FT                   /note="Interchain"
FT                   /evidence="ECO:0000269|PubMed:10501505"
FT   DISULFID        208
FT                   /note="Interchain"
FT                   /evidence="ECO:0000269|PubMed:10501505"
FT   VARIANT         99
FT                   /note="I -> L (in strain: 776)"
FT   MUTAGEN         49
FT                   /note="E->A: 99% loss of infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:12805453"
FT   MUTAGEN         50
FT                   /note="C->S: No effect on infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:15567029"
FT   MUTAGEN         88
FT                   /note="C->S: 99% loss of infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:15567029"
FT   MUTAGEN         158
FT                   /note="E->K,R: Complete loss of infectivity ex vivo,
FT                   defective in nuclear entry."
FT                   /evidence="ECO:0000269|PubMed:17360742"
FT   MUTAGEN         161
FT                   /note="E->K,R: 95% loss of infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:17360742"
FT   MUTAGEN         217
FT                   /note="E->K,R: 99% loss of infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:12805453"
FT   MUTAGEN         244
FT                   /note="V->E: Complete loss of infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:16940501"
FT   MUTAGEN         246
FT                   /note="L->E: Complete loss of infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:16940501"
FT   MUTAGEN         255
FT                   /note="C->S: Complete loss of infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:15567029"
FT   MUTAGEN         268
FT                   /note="C->S: No effect on infectivity ex vivo."
FT                   /evidence="ECO:0000269|PubMed:15567029"
FT   MUTAGEN         331
FT                   /note="E->K,R: Complete loss of infectivity ex vivo,
FT                   defective in adsorbing to cells."
FT                   /evidence="ECO:0000269|PubMed:12805453"
FT   HELIX           33..37
FT                   /evidence="ECO:0007829|PDB:1SVA"
FT   STRAND          45..52
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   HELIX           61..63
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   HELIX           83..85
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          90..95
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          105..121
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   HELIX           123..127
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          130..132
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          135..137
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          145..147
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          149..158
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          161..164
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   HELIX           185..188
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   HELIX           192..194
FT                   /evidence="ECO:0007829|PDB:1SVA"
FT   STRAND          195..197
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   TURN            201..203
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   TURN            206..208
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          209..211
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   TURN            213..215
FT                   /evidence="ECO:0007829|PDB:1SVA"
FT   STRAND          219..226
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          234..240
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   HELIX           256..258
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          259..272
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          278..282
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          285..297
FT                   /evidence="ECO:0007829|PDB:3BWR"
FT   STRAND          304..306
FT                   /evidence="ECO:0007829|PDB:1SVA"
FT   HELIX           324..326
FT                   /evidence="ECO:0007829|PDB:1SVA"
FT   STRAND          348..351
FT                   /evidence="ECO:0007829|PDB:1SVA"
FT   STRAND          353..359
FT                   /evidence="ECO:0007829|PDB:1SVA"
SQ   SEQUENCE   362 AA;  39906 MW;  81C28EB7EA51D398 CRC64;
     MAPTKRKGSC PGAAPKKPKE PVQVPKLVIK GGIEVLGVKT GVDSFTEVEC FLNPQMGNPD
     EHQKGLSKSL AAEKQFTDDS PDKEQLPCYS VARIPLPNIN EDLTCGNILM WEAVTVKTEV
     IGVTAMLNLH SGTQKTHENG AGKPIQGSNF HFFAVGGEPL ELQGVLANYR TKYPAQTVTP
     KNATVDSQQM NTDHKAVLDK DNAYPVECWV PDPSKNENTR YFGTYTGGEN VPPVLHITNT
     ATTVLLDEQG VGPLCKADSL YVSAVDICGL FTNTSGTQQW KGLPRYFKIT LRKRSVKNPY
     PISFLLSDLI NRRTQRVDGQ PMIGMSSQVE EVRVYEDTEE LPGDPDMIRY IDEFGQTTTR
     MQ
//
